SEC Form 4 · accession 0001651844-17-000002
NYMOX PHARMACEUTICAL CORP · NYMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James George Robinson
Director
Period of report
Mar 8, 2017
Accepted (ET)
Mar 29, 2017 · 10:01 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001018735
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 8, 2017 | P | 528 | $3.49 | A | 2,906,078 | D | |
| Common Stock | Mar 8, 2017 | P | 3,500 | $3.50 | A | 2,911,578 | D | |
| Common Stock | Mar 8, 2017 | P | 114 | $3.53 | A | 2,911,692 | D | |
| Common Stock | Mar 8, 2017 | P | 900 | $3.54 | A | 2,912,592 | D | |
| Common Stock | Mar 8, 2017 | P | 100 | $3.57 | A | 2,912,692 | D | |
| Common Stock | Mar 8, 2017 | P | 900 | $3.58 | A | 2,913,592 | D | |
| Common Stock | Mar 8, 2017 | P | 110 | $3.59 | A | 2,913,702 | D | |
| Common Stock | Mar 8, 2017 | P | 43,848 | $3.60 | A | 2,957,550 | D | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust |
Table II — derivative securities
No Table II lines on this filing.